Brigham and Women’s Hospital researchers in the US have found that synthetic silicate nanoplatelets induce stem cells to become bone cells without additional bone-inducing factors.
This discovery has been determined by the bone matrix formation in lab results.
Based on preliminary studies, researchers believe that bioactive nanoplatelets could be used to develop injectable tissue repair matrixes and therapeutic agents for stimulating specific cellular responses in bone-related tissue engineering.
Silicate nanoplatelets may potentially lead to new materials that can direct stem cell differentiation and facilitate functional tissue formation.
Read more at Brigham and Women's Hospital